Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1204 participants.

Also called NCT07454707

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,204 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07454707
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07454707. Randomized; single masking; primary purpose prevention. Start 2026-11 (anticipated); primary completion 2031-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
Acronym
STROKE75+
Condition
Stroke, Ischemic
Intervention (Drug)
Edoxaban 15 mg
Intervention (Drug)
Aspirin or clopidogrel
Lead sponsor
Sunnybrook Health Sciences Centre (class: other)

Record details

Record id
cardio:ct-nct07454707
Content hash
eb6de9382fdcb765f65024594f94deaf3321c3076d73563b9cf9ddda2dd470c3